id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8718 R29460 |
Korelitz (control exposed to MMI), 2013 | Atrial or ventricular septal heart defects (ASD/VSD) | 3 months (or more) before pregnancy or during pregnancy | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No |
1.54 [0.20;11.91] C excluded (control group) |
13/915 1/108 | 14 | 915 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3387 R6309 |
Korelitz (control exposed to MMI), 2013 | Atrial or ventricular septal heart defects (ASD/VSD) | 3 months (or more) before pregnancy or during pregnancy | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No |
1.54 [0.20;11.91] C excluded (control group) |
13/915 1/108 | 14 | 915 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3388 R6317 |
Korelitz (control unexposed, disease free), 2013 | Atrial or ventricular septal heart defects (ASD/VSD) | 3 months (or more) before pregnancy or during pregnancy | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No |
1.13 [0.66;1.96] C excluded (control group) |
13/915 7,970/634,858 | 7,983 | 915 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3389 R6325 |
Korelitz (control unexposed, sick), 2013 | Atrial or ventricular septal heart defects (ASD/VSD) | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort (claims database) | unexposed, sick | Adjustment: No |
1.10 [0.59;2.05] C excluded (exposition period) |
13/915 42/3,236 | 55 | 915 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 0 studies | NaN [NaN;NaN] | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |